The bears worry about Astra was turned around yesterday when the drugs heavyweight produced a 136 percent surge in sales of its replacement ulcer drug.
The generic competition has wrecked their older dugs sales bu this was too be expected.
Is the tide turning?
Looks better for the moment next GSK and their overpaid directors,according to the shareholders anyway.

http://www.polskishop.com/1_05_03.htm
STOCKSURGERY
www.polskishop.com